145 related articles for article (PubMed ID: 11042307)
21. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
Loncaster JA; Cooper RA; Logue JP; Davidson SE; Hunter RD; West CM
Br J Cancer; 2000 Sep; 83(5):620-5. PubMed ID: 10944602
[TBL] [Abstract][Full Text] [Related]
22. Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis.
Wang S; Wang L; Zhang Y; Liu Y; Meng F; Ma J; Shang P; Gao Y; Huang Q; Chen X
Jpn J Clin Oncol; 2015 Sep; 45(9):812-8. PubMed ID: 26117495
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
[TBL] [Abstract][Full Text] [Related]
25. Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status.
Maeda T; Matsumura S; Hiranuma H; Jikko A; Furukawa S; Ishida T; Fuchihata H
J Clin Pathol; 1998 Oct; 51(10):771-5. PubMed ID: 10023341
[TBL] [Abstract][Full Text] [Related]
26. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
[TBL] [Abstract][Full Text] [Related]
27. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis.
O-charoenrat P; Rhys-Evans P; Eccles SA
Cancer; 2001 Aug; 92(3):556-68. PubMed ID: 11505400
[TBL] [Abstract][Full Text] [Related]
28. Expression of vascular endothelial growth factor C correlates with a poor prognosis based on analysis of prognostic factors in patients with cervical carcinomas.
Ma DM; Xu YP; Zhu L
J Obstet Gynaecol Res; 2011 Nov; 37(11):1519-24. PubMed ID: 21676077
[TBL] [Abstract][Full Text] [Related]
29. Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma.
Maeda K; Nishiguchi Y; Yashiro M; Yamada S; Onoda N; Sawada T; Kang SM; Hirakawa K
Int J Mol Med; 2000 Apr; 5(4):373-8. PubMed ID: 10719053
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma.
Imoto H; Osaki T; Taga S; Ohgami A; Ichiyoshi Y; Yasumoto K
J Thorac Cardiovasc Surg; 1998 May; 115(5):1007-14. PubMed ID: 9605068
[TBL] [Abstract][Full Text] [Related]
32. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
33. P27 as a prognostic factor of early cervical carcinoma.
Bouda J; Hes O; Koprivova M; Pesek M; Svoboda T; Boudova L
Int J Gynecol Cancer; 2013 Jan; 23(1):164-9. PubMed ID: 23221604
[TBL] [Abstract][Full Text] [Related]
34. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS
Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952
[TBL] [Abstract][Full Text] [Related]
35. Outcome and prognostic factors of laparoscopic radical hysterectomy and pelvic lymphadenectomy in 148 patients with stage IB1 cervical cancer.
Yan X; Li G; Shang H; Lin F; Yang X; Zheng F
Int J Gynecol Cancer; 2012 Feb; 22(2):286-90. PubMed ID: 22146764
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of the relationship between clinicopathological features and pelvic lymph node metastasis in patients with early stage squamous cell carcinoma of the uterine cervix].
Tian QF; Wang XY; Lü WG; Ye F; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):760-3. PubMed ID: 19087544
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
38. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
Tamura M; Ohta Y
Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
[TBL] [Abstract][Full Text] [Related]
39. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.
Eppenberger U; Kueng W; Schlaeppi JM; Roesel JL; Benz C; Mueller H; Matter A; Zuber M; Luescher K; Litschgi M; Schmitt M; Foekens JA; Eppenberger-Castori S
J Clin Oncol; 1998 Sep; 16(9):3129-36. PubMed ID: 9738585
[TBL] [Abstract][Full Text] [Related]
40. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
